Keerat Kaur

730 total citations
22 papers, 388 citations indexed

About

Keerat Kaur is a scholar working on Molecular Biology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Keerat Kaur has authored 22 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 7 papers in Surgery and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Keerat Kaur's work include RNA Interference and Gene Delivery (11 papers), Virus-based gene therapy research (6 papers) and Tissue Engineering and Regenerative Medicine (6 papers). Keerat Kaur is often cited by papers focused on RNA Interference and Gene Delivery (11 papers), Virus-based gene therapy research (6 papers) and Tissue Engineering and Regenerative Medicine (6 papers). Keerat Kaur collaborates with scholars based in United States, India and Panama. Keerat Kaur's co-authors include Lior Zangi, Ajit Magadum, Leonard M. Eisenberg, Carol A. Eisenberg, Jinpu Yang, Mohammad Tofael Kabir Sharkar, Elena Chepurko, Nishat Sultana, Yoav Hadas and Ann Kurian and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of Medicinal Chemistry.

In The Last Decade

Keerat Kaur

18 papers receiving 379 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keerat Kaur United States 10 335 78 77 60 38 22 388
Alexandria M. Doerfler United States 7 291 0.9× 132 1.7× 66 0.9× 50 0.8× 11 0.3× 8 367
Meng Wu United States 10 195 0.6× 55 0.7× 33 0.4× 32 0.5× 46 1.2× 21 313
Costin M. Gherghe United States 7 417 1.2× 29 0.4× 143 1.9× 101 1.7× 28 0.7× 8 505
Mohammad Tofael Kabir Sharkar United States 8 424 1.3× 79 1.0× 133 1.7× 75 1.3× 46 1.2× 12 483
Maolin Ge China 9 146 0.4× 32 0.4× 27 0.4× 23 0.4× 49 1.3× 19 240
Andreas Würch Germany 7 220 0.7× 56 0.7× 50 0.6× 43 0.7× 29 0.8× 9 409
Rustam Bagirzadeh United States 8 114 0.3× 76 1.0× 46 0.6× 37 0.6× 23 0.6× 11 301
Paris Margaritis United States 14 270 0.8× 198 2.5× 26 0.3× 28 0.5× 7 0.2× 36 599
Berit Genz Germany 10 105 0.3× 35 0.4× 11 0.1× 69 1.1× 56 1.5× 25 311
Nehal Gosalia United States 13 312 0.9× 124 1.6× 6 0.1× 54 0.9× 90 2.4× 18 486

Countries citing papers authored by Keerat Kaur

Since Specialization
Citations

This map shows the geographic impact of Keerat Kaur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keerat Kaur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keerat Kaur more than expected).

Fields of papers citing papers by Keerat Kaur

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keerat Kaur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keerat Kaur. The network helps show where Keerat Kaur may publish in the future.

Co-authorship network of co-authors of Keerat Kaur

This figure shows the co-authorship network connecting the top 25 collaborators of Keerat Kaur. A scholar is included among the top collaborators of Keerat Kaur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keerat Kaur. Keerat Kaur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Anand, Puneet, et al.. (2025). Metabolic Stability and Targeted Delivery of Oligonucleotides: Advancing RNA Therapeutics Beyond The Liver. Journal of Medicinal Chemistry. 68(7). 6870–6896. 7 indexed citations
4.
Żak, Magdalena M., et al.. (2023). Modified mRNA Formulation and Stability for Cardiac and Skeletal Muscle Delivery. Pharmaceutics. 15(9). 2176–2176. 8 indexed citations
5.
Eisenberg, Leonard M., et al.. (2023). Dexamethasone Treatment Preserves the Structure of Adult Cardiac Explants and Supports Their Long-Term Contractility In Vitro. SHILAP Revista de lepidopterología. 3(3). 360–373.
6.
Kaur, Keerat, et al.. (2023). A single-nucleotide resolution capillary gel electrophoresis workflow for poly(A) tail characterization in the development of mRNA therapeutics and vaccines. Journal of Pharmaceutical and Biomedical Analysis. 236. 115692–115692. 9 indexed citations
7.
Kaur, Shubhdeep, et al.. (2022). Comparison of intrathecal bupivacaine-fentanyl and bupivacaine-butorphanol combinations for joint replacement surgeries. Journal of Anaesthesiology Clinical Pharmacology. 38(1). 79–83. 2 indexed citations
8.
Magadum, Ajit, Neha Singh, Ann Kurian, et al.. (2021). Therapeutic Delivery of Pip4k2c‐Modified mRNA Attenuates Cardiac Hypertrophy and Fibrosis in the Failing Heart. Advanced Science. 8(10). 2004661–2004661. 24 indexed citations
9.
Kaur, Keerat & Lior Zangi. (2020). Modified mRNA as a Therapeutic Tool for the Heart. Cardiovascular Drugs and Therapy. 34(6). 871–880. 32 indexed citations
10.
Kaur, Keerat, Nishat Sultana, Ajit Magadum, et al.. (2020). Delivery of Modified mRNA in a Myocardial Infarction Mouse Model. Journal of Visualized Experiments. 3 indexed citations
11.
Sultana, Nishat, Yoav Hadas, Mohammad Tofael Kabir Sharkar, et al.. (2020). Optimization of 5′ Untranslated Region of Modified mRNA for Use in Cardiac or Hepatic Ischemic Injury. Molecular Therapy — Methods & Clinical Development. 17. 622–633. 31 indexed citations
12.
Kaur, Keerat, Nishat Sultana, Yoav Hadas, et al.. (2020). Delivery of Modified mRNA in a Myocardial Infarction Mouse Model. Journal of Visualized Experiments. 6 indexed citations
13.
Kaur, Keerat, Ann Kurian, Magdalena M. Żak, et al.. (2020). Abstract 17357: Direct Cardiac Reprogramming Using Combinatorial Modified mRNA. Circulation. 142(Suppl_3).
14.
Hadas, Yoav, Nishat Sultana, Mohammad Tofael Kabir Sharkar, et al.. (2019). Optimizing Modified mRNA In Vitro Synthesis Protocol for Heart Gene Therapy. Molecular Therapy — Methods & Clinical Development. 14. 300–305. 33 indexed citations
15.
Magadum, Ajit, Keerat Kaur, & Lior Zangi. (2018). mRNA-Based Protein Replacement Therapy for the Heart. Molecular Therapy. 27(4). 785–793. 132 indexed citations
17.
Yang, Jinpu, et al.. (2015). Inhibition of G9a Histone Methyltransferase Converts Bone Marrow Mesenchymal Stem Cells to Cardiac Competent Progenitors. Stem Cells International. 2015. 1–12. 14 indexed citations
18.
Kaur, Keerat, Jinpu Yang, Carol A. Eisenberg, & Leonard M. Eisenberg. (2014). 5-Azacytidine Promotes the Transdifferentiation of Cardiac Cells to Skeletal Myocytes. Cellular Reprogramming. 16(5). 324–330. 26 indexed citations
19.
Yang, Jinpu, Keerat Kaur, Grazia Iaffaldano, et al.. (2012). The Histone Methyltransferase Inhibitor BIX01294 Enhances the Cardiac Potential of Bone Marrow Cells. Stem Cells and Development. 22(4). 654–667. 21 indexed citations
20.
Kaur, Keerat, et al.. (2001). Glucose-6-phosphate dehydrogenase deficiency in blood donors: screening by micromethaemoglobin reduction test.. PubMed. 44(1). 23–5. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026